title: Antimalarial clinical trial protocols--can we avoid risk to patients?
authors.affiliation: Department of Clinical Pharmacology, Seth G.S. Medical College, Parel, Mumbai, India.
authors.forename: N J
authors.initials: NJ
authors.lastname: Gogtay
authors.forename: A R
authors.initials: AR
authors.lastname: Chogle
authors.forename: J S
authors.initials: JS
authors.lastname: Sorabjee
authors.forename: S N
authors.initials: SN
authors.lastname: Marathe
authors.forename: N A
authors.initials: NA
authors.lastname: Kshirsagar
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use*; D004351:Drug Resistance; D017809:Fatal Outcome; D006801:Humans; D016778:Malaria, Falciparum / Q000150:complications / Q000188:drug therapy*; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012128:Respiratory Distress Syndrome / Q000209:etiology
chemical_list: D000962:Antimalarials; D002738:Chloroquine